(S)-3-(6-Fluoro-1-oxo-5-(piperazin-1-yl)isoindolin-2-yl)piperidine-2,6-dione benzenesulfonate

Catalog No. :
ACOCVH105
CAS No. :
2504914-78-5
Molecular Formula :
C23H25FN4O6S
Molecular Weight :
504.54

IUPAC Name:(S)-3-(6-fluoro-1-oxo-5-(piperazin-1-yl)isoindolin-2-yl)piperidine-2,6-dione benzenesulfonate

(S)-3-(6-Fluoro-1-oxo-5-(piperazin-1-yl)isoindolin-2-yl)piperidine-2,6-dione benzenesulfonate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$410.00Login to see priceInquiryInquiry
250mg98%$708.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-3-(6-Fluoro-1-oxo-5-(piperazin-1-yl)isoindolin-2-yl)piperidine-2,6-dione benzenesulfonate
IUPAC Name(S)-3-(6-fluoro-1-oxo-5-(piperazin-1-yl)isoindolin-2-yl)piperidine-2,6-dione benzenesulfonate
Molecular FormulaC23H25FN4O6S
Molecular Weight504.54
SMILESO=S(O)(C1=CC=CC=C1)=O.O=C2C3=CC(F)=C(N4CCNCC4)C=C3CN2[C@]5([H])C(NC(CC5)=O)=O
InChI KeyXSVMHPMYURSHGO-ZOWNYOTGSA-N
SynonymSugammadex sodium Imputity
CAS No.2504914-78-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACOCVH105 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOCVH105 route product structure diagram
    ACOCVH1052504914-78-5
Inquiry

2. ACOCVH105 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBKQV982 route compound structure diagram
    ACBKQV982334-22-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOCVH105 route product structure diagram
    ACOCVH1052504914-78-5
Inquiry

Comments (0)